Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New drug targets in psychiatry: Neurobiological considerations in the genomics era.

Journal article

Harrison PJ. et al, (2022), Neurosci Biobehav Rev, 139

Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia.

Journal article

Mould AW. et al, (2022), CNS Drugs, 36, 1 - 16

Targeting synaptic plasticity in schizophrenia: insights from genomic studies.

Journal article

Mould AW. et al, (2021), Trends Mol Med, 27, 1022 - 1032

Cellular calcium in bipolar disorder: systematic review and meta-analysis.

Journal article

Harrison PJ. et al, (2021), Mol Psychiatry, 26, 4106 - 4116

Smchd1 regulates long-range chromatin interactions on the inactive X chromosome and at Hox clusters.

Journal article

Jansz N. et al, (2018), Nat Struct Mol Biol, 25, 766 - 777

PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation.

Journal article

Almeida M. et al, (2017), Science, 356, 1081 - 1084

Load More